Li-Jun Duan
11 Papers
16 Citations
Li-Jun Duan is an academic researcher. The author has contributed to research in topics: Medicine & Antibody. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.
Guo-Lin Wang,Zhuang-Ye Wang,Li-Jun Duan,Qing-Chuan Meng,Ming-Dong Jiang,Jing Cao,Lin Yao,Ka-Li Zhu,Wu-Chun Cao,Mai-Juan Ma +9 more
TL;DR: Neutralization of SARS-CoV-2 Variants by Convalescent and Vaccinee Serum Analysis of serum samples from patients convalescing after SARS CoV2 infection and after vaccination with BBIBP-CorV or Cor
176
Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients.
Xiang-Na Zhao,Yue You,Yue You,Xiao-Ming Cui,Huixia Gao,Guo-Lin Wang,Sheng-Bo Zhang,Sheng-Bo Zhang,Lin Yao,Li-Jun Duan,Ka-Li Zhu,Yu-Ling Wang,Li Li,Jian-Hua Lu,Hai-Bin Wang,Jing-Fang Fan,Huanwei Zheng,Erhei Dai,Lu-Yi Tian,Lu-Yi Tian,Mai-Juan Ma +20 more
TL;DR: This article performed single-cell transcriptome and T-cell/B-cell receptor (TCR/BCR) sequencing in 37 longitudinal collected peripheral blood mononuclear cell samples from asymptomatic, moderate and severe patients with healthy controls.
Neutralizing immunity against SARS-CoV-2 Omicron BA.1 by infection and vaccination
Li-Jun Duan,Wen Jiang,Zhuang Wang,Lin Yao,Ka-Li Zhu,Q. Meng,Baoming Wang,Li-Bo Li,Guo-Lin Wang,Mai-Juan Ma +9 more
TL;DR: In this paper , the authors examined the neutralization activity of sera collected from previously SARS-CoV-2-infected individuals and naive individuals who received BBIBP-CorV or CoronaVac to BA.1 and the earlier variants Alpha, Beta, and Delta.
10
Delta infection following vaccination elicits potent neutralizing immunity against the SARS-CoV-2 Omicron
Ka-Li Zhu,Huixia Gao,Lin Yao,Jun Rong,Li Yang,Zhi Zhang,Ping Jiang,Li-Jun Duan,Guo-Lin Wang,Erhei Dai,Mai-Juan Ma +10 more
TL;DR: This study demonstrates that breakthrough infection of Delta substantially induced high potency humoral immune response against the Omicron variant and other emerged variants.
SARS-CoV-2 vaccine-induced antibody and T cell response in SARS-CoV-1 survivors
TL;DR: In this article , a single dose of Ad5-nCoV-immunized SARS-CoV1 survivors 6 months after vaccination was found to have a stronger neutralizing antibody and cross-reactive T cell responses.
7